All questionsSpecific populations: Linzess (linaclotide), all indications4 questions · 2 sourcesPregnancy and breastfeedingCan Linzess be used during pregnancy?“Linaclotide and its active metabolite are negligibly absorbed systemically following oral administration [see Clinical Pharmacology (12.3)], and maternal use is not expected to result in fetal exposure to the drug. The available data on LINZESS use in pregnant women are not sufficient to inform any drug-associated risk for major birth defects and miscarriage. In animal developmental studies, no effects on embryo-fetal development were observed with oral administration of linaclotide in rats and rabbits during organogenesis at doses much higher than the maximum recommended human dosage. Severe maternal toxicity associated with effects on fetal morphology were observed in mice (see Data).” (opens the source at this quote in a new tab)CopyFlagCan Linzess be used while breastfeeding?“Linaclotide and its active metabolite were not detected in the milk of lactating women (see Data). In adults, concentrations of linaclotide and its active metabolite were below the limit of quantitation in plasma following multiple doses of LINZESS [see Clinical Pharmacology (12.3)]. Maternal use of LINZESS is not expected to result in exposure to linaclotide or its active metabolite in breastfed infants. There is no information on the effects of linaclotide or its active metabolite on milk production. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for LINZESS and any potential adverse effects on the breastfed infant from LINZESS or from the underlying maternal condition.” (opens the source at this quote in a new tab)CopyFlag“Following oral administration of 72 mcg, 145 mcg, or 290 mcg of LINZESS once daily for 3 days to breastfeeding mothers taking linaclotide therapeutically, the concentrations of linaclotide and its metabolite were below the limits of quantitation (<0.25 ng/mL and <1 ng/mL, respectively) in all breast milk samples collected over 24 hours.” (opens the source at this quote in a new tab)CopyFlagSpecific populationsDoes Linzess need a dose adjustment for kidney or liver impairment?“Dosing adjustments for patients with renal or hepatic impairment are not required” (opens the source at this quote in a new tab)CopyFlag“Renal or hepatic impairment is not expected to affect the clearance of linaclotide or the active metabolite because linaclotide metabolism occurs within the gastrointestinal tract” (opens the source at this quote in a new tab)CopyFlag“and plasma concentrations are not measurable in plasma following administration of the recommended dosage.” (opens the source at this quote in a new tab)CopyFlagWhat happens after a Linzess overdose?“Single LINZESS doses of 2897 mcg were administered to 22 healthy subjects; the safety profile in these subjects was consistent with that in the overall LINZESS-treated population, with diarrhea being the most commonly reported adverse reaction.” (opens the source at this quote in a new tab)CopyFlag